Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bedbrook

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|February 28, 2020
[Executive Summary of ARIA 2019: Integrated care pathways for allergic rhinitis in Argentina, Spain and Mexico]Juan Carlos Ivancevich, Victoria Cardona, Désirée Larenas-Linnemann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 2019
Adherence to treatment in allergic rhinitis using mobile technology. The MASK StudyEnrica Menditto, Elisio Costa, Luis Midão, et al.
Journal of Thoracic Disease|October 29, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Journal of Thoracic Disease|September 28, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
Allergy|May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important differenceBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
The Lancet. Digital Health|March 5, 2023
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data studyBernardo Sousa-Pinto, Cristina Jácome, Ana Margarida Pereira, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2017
Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypesJosep M Anto, Jean Bousquet, Mubeccel Akdis, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|February 28, 2020
[Executive Summary of ARIA 2019: Integrated care pathways for allergic rhinitis in Argentina, Spain and Mexico]Juan Carlos Ivancevich, Victoria Cardona, Désirée Larenas-Linnemann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 2019
Adherence to treatment in allergic rhinitis using mobile technology. The MASK StudyEnrica Menditto, Elisio Costa, Luis Midão, et al.
Journal of Thoracic Disease|October 29, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects modelBernardo Sousa-Pinto, Luís Filipe Azevedo, Ana Sá-Sousa, et al.
Journal of Thoracic Disease|September 28, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
Allergy|May 14, 2022
Comparison of rhinitis treatments using MASK-air® data and considering the minimal important differenceBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
The Lancet. Digital Health|March 5, 2023
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data studyBernardo Sousa-Pinto, Cristina Jácome, Ana Margarida Pereira, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2017
Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypesJosep M Anto, Jean Bousquet, Mubeccel Akdis, et al.
Pageof 11